Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,866
Sort by:
Turkey Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering:Turkey Clinical Trials M...
July 2024
500 pages
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-cancer (NIPT, Infectious)), Sample Type (Blood) - Global Forecast to 2029
US$ 3,217.50
... during the forecast period” Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ ...
May 2024
328 pages
Asia Pacific Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
US$ 3,550.00
The Asia Pacific breast cancer therapeutics market was valued at US$ 6,986.37 million in 2022 and is expected to reach US$ 15,819.83 million by 2030; it is estimated to grow at a CAGR of 10.8% from 20...
March 2024
106 pages
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
US$ 4,175.00
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospita...
February 2024
209 pages
Multi-Cancer Diagnostic Tests: Global Market Outlook
US$ 3,500.00
Report : The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and chal...
February 2024
50 pages
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
US$ 5,500.00
The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in ... should reach $27.4 billion in 2021, with a CAGR of 7.2 %. Surgical and radiation therapy as a segment reached nearly $14.4 billion in 2016 and should reach $20.8 billion ...
January 2024
157 pages
Global Gastric Cancer Diagnostic Market: Analysis By Product Type (Reagents and Consumables and Instruments), By Disease Type (Adenocarcinoma, Gastric Lymphoma and Others), By End User (Hospitals, Oncology Specialty Clinics, Diagnostic Labs, Cancer Research Institutes And Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
US$ 2,250.00
Gastric cancer diagnostic involves a comprehensive process of identifying stomach cancer through clinical evaluation, imaging studies like endoscopy and CT scans, biopsy for tissue examination, and bl...
January 2024
143 pages
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
300 pages
Cancer Diagnostic Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
450 pages
Cancer Diagnostics Companies in China
US$ 1,800.00
This study focuses on China’s Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
October 2023
53 pages
Cancer Diagnostics Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Cancer Diagnostics industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
October 2023
103 pages
Cancer Diagnostics Markets in China
US$ 4,000.00
China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
October 2023
213 pages
Oncology Collaboration and Licensing Deals 2019-2023
US$ 3,995.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
October 2023
1600 pages
Global Cervical Cancer Therapeutics Market 2023
US$ 3,350.00
The global cervical cancer therapeutics market was valued at USD 5.66 billion in 2022 and is projected to reach USD 7.14 billion by 2029, exhibiting a compound annual growth rate of 3.3% between 2023...
September 2023
94 pages
Pancreatic Cancer Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type {Diagnostic Imaging Tests (CT scan, MRI, Ultrasound, Others), Biopsy, Blood Tests, Liver Function Tests, Others}, By Cancer Type (Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Colloid Carcinoma, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), Region and Competition
US$ 4,900.00
Global Pancreatic Cancer Diagnostics Market is poised to grow at an impressive rate during the forecast period on account of the increasing incidence of pancreatic cancer, rising demand for minimally...
August 2023
113 pages
Oncology Biomarkers: Global Markets
US$ 5,500.00
Report : This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall in...
June 2023
186 pages
Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application, End User, and Region Analysis - Analysis and Forecast, 2023-2032
US$ 4,400.00
Global Multicancer Screening Market Industry Overview The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during...
April 2023
228 pages
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
US$ 4,950.00
... various cancer/tumor profiling technologies and their adoption pattern. It aims at estimating the market size and future growth potential of cancer/tumor profiling market and the different segments such as by technology, cancer ...
November 2022
295 pages
Interventional Oncology Global Market - Forecast To 2029
US$ 4,950.00
Interventional Oncology (IO) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, B...
September 2022
378 pages
Head and Neck Cancer Therapeutics: Global Markets
US$ 5,500.00
Report : This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of quantitative and qualitative data, to help businesses develop gr...
August 2022
148 pages
RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), End User (Pharma, Payer) - Global Forecast to 2029
US$ 4,175.00
RWE Oncology Solutions Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillanc...
July 2022
200 pages
Monoclonal Antibodies for Oncology: Global Markets
US$ 5,500.00
Report : The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies...
June 2022
124 pages
Cancer Supportive Care Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (G-CSFs, ESAs, Opioids), By Region (APAC, North America, Europe, MEA), And Segment Forecasts, 2022 - 2030
US$ 5,950.00
... to drive growth of the global cancer supportive care drugs market. High efficiency of these drugs in controlling the adverse effects of cancer and its treatment is projected ... major brands such as Epogen North America led the cancer supportive care drugs market in 2018 and is expected to maintain its position ...
May 2022
89 pages
Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods {Biopsy, Imaging, Endoscopy, Others} v/s Treatment Type {Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy}), By Treatment Type (By Disease Indication {Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer}, By Route of Administration {Injectable, Oral}, By Therapeutic Class {PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors}), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Company, Opportunities and Forecast, 2027
US$ 4,900.00
Global head and neck cancer therapeutics market value in 2021 was USD2024.33 million, which is expected to grow further with a CAGR of 7.22% during the forecast period, 2023-2027, to achieve the marke...
April 2022
358 pages
Artificial Intelligence in the Cancer Market
US$ 4,950.00
Product Overview For years, artificial intelligence (AI) has caught society's interest and generated excitement about its potential tenhance our lives. AI is already a part of our everyday lives, as w...
April 2022
334 pages